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Available online 18 April 2008The human cytomegalovirus tegument protein pp71 localizes to the nucleus immediately upon infection, and
functions to initiate viral gene expression. Analysis of a series of random insertion mutations revealed that
sequences within the mid region (MR) of pp71 are important for localization to the nucleus. Fusion of MR
sequences with eGFP revealed that amino acids 94 to 300 were sufﬁcient to target proteins to the nucleus.
Random substitution mutagenesis within this domain resulted in two double substitution mutants,
pp71P203T/T223M and pp71T228M/L275Q, with a predominantly cytoplasmic localization. Disruption of
nuclear targeting resulted in relocalization of the fusion proteins to a distinct perinuclear region. Using
tandem mass spectrometry, we determined that threonine 223 can be phosphorylated. Mutation of this
residue to a phosphomimetic amino acid resulted in abrogation of nuclear targeting. These results strongly
suggest that the intracellular trafﬁcking of pp71 is regulated by phosphorylation.






Human cytomegalovirus (HCMV), a member of the beta subgroup of
herpesviruses, is a ubiquitous humanpathogen, which infects 40 to 60%
of the human population in developed countries (Mocarski et al., 2007).
HCMV infection is usually asymptomatic andmaintains a latent state for
the lifetime of the individual. However, primary infection or reactivation
of a latent infection can cause severe morbidity and mortality in
immunocompromised individuals such as AIDS patients and organ
transplant patients (Grifﬁths, 2006; Snydman, 2006). The HCMV
genome is a linear double-stranded DNA of approximately 235 kb,
which is enclosed in an icosahedral capsid surrounded by a tegument
layer, andﬁnallyenveloped in a lipidbilayer embeddedwith anumberof
virus-encoded glycoproteins (Mocarski et al., 2007). HCMV gene
expression is separated into three temporal phases termed immediate
early (IE), early and late (Fortunato and Spector, 1999; Mocarski et al.,
2007). Expression of immediately early genes begins immediately after
virus entry, and encodes critical viral proteins, which regulate viral early
and late gene expression (Anders et al., 2007; Mocarski et al., 2007).
The tegument layer of HCMV consists of at least 25 viral proteins,
and the majority of the tegument proteins are phosphoproteins
(Baldick and Shenk, 1996; Mocarski et al., 2007; Varnum et al., 2004).
As might be predicted, tegument proteins can play critical roles in
virus assembly and particle stability (AuCoin et al., 2006; Britt et al.,
2004; Jones and Lee, 2004; Lorz et al., 2006; Munger et al., 2006; Silva
et al., 2003). In addition, a number of the HCMV tegument proteins
have key functions in the initiation of viral infection. For example, the
tegument protein pp65 is the most abundant protein made duringl rights reserved.replication (Gibson, 1983) and is thought to be involved in immune
evasion by modulating interferon signaling (Abate et al., 2004;
Browne and Shenk, 2003). The 559 amino acid pp71 protein, which
is encoded by the UL82 gene, was the ﬁrst HCMV tegument protein to
be characterized as a transactivator, activating the major immediate
early promoter and initiating viral gene expression (Bresnahan and
Shenk, 2000; Chau et al., 1999; Liu and Stinski, 1992). More recently, a
number of other tegument proteins including pIRS1/pTRS1 (Iskenderian
et al., 1996; Kerry et al., 1996; Romanowski and Shenk, 1997), pUL26
(Stamminger et al., 2002), ppUL35 (Schierling et al., 2004) and ppUL69
(Winkler et al., 1994) have been added to the list of tegument
transactivators of viral gene expression. The pIRS1/pTRS1 proteins
have also been shown to assist in the evasion of the interferon response
by relocalizing PKR to the nucleus (Hakki et al., 2006).
Upon fusion of the viral envelope with the cell membrane, the viral
capsid rapidly localizes to the nucleus (Ogawa-Goto et al., 2003). In
addition, some viral tegument proteins including pp71 are targeted to
the nucleus (Hensel et al., 1995, 1996), consistent with their role in
initiating viral gene expression. The pp71 protein can also act with the
immediate early gene products to activate early promoters of HCMV
(Chau et al., 1999), and interacts with the cellular protein hDaxx to
facilitate viral transcription at nuclear domains 10 (ND10) (Cantrell
and Bresnahan, 2005, 2006; Hofmann et al., 2002; Ishov et al., 2002;
Preston and Nicholl, 2006; Saffert and Kalejta, 2006). Furthermore,
pp71 has been shown to enhance the infectivity of viral DNA and
thereby accelerate the process of virus infection (Baldick et al., 1997).
In addition, pp71 can bind to the retinoblastoma protein (Rb),
resulting in its degradation and enhanced progression through the
cell cycle (Kalejta et al., 2003; Kalejta and Shenk, 2003a,b), although
this interaction is not important for the transcriptional activity of pp71
(Cantrell and Bresnahan, 2005).
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when assessed in nonpermissive cell lines such as undifferentiated
THP-1 cells, suggesting that the nuclear localization of this protein
plays a key role in the initiation of viral infection and that nuclear
import is a regulated process (Saffert and Kalejta, 2007). However,
little is known about the mechanism by which pp71 localizes to the
nucleus. In addition, at the late phase of viral infection, pp71 relocates
to the cytoplasm in dense perinuclear structures (Hensel et al., 1996),
presumably sites of virion tegumentation. These data suggest that
pp71 contains multiple subcellular targeting sequences. In the current
study, we investigated the regions of pp71 responsible for nuclear
accumulation of this protein. Our studies reveal that sequences within
the mid region (MR) of pp71 are responsible for nuclear localization,
even though this region contains no sequences matching known NLS
motifs (Christophe et al., 2000; Dingwall and Laskey, 1991; Macara,
2001). The disruption of sequences required for nuclear targeting
within the MR domain results in protein localization to a distinct
perinuclear region that may correspond to tegumentation sites.
Further, our studies suggest that the phosphorylation status of the
threonine residue at amino acid position 223 plays a critical role in the
regulation of pp71 subcellular trafﬁcking.
Results
Identiﬁcation of pp71 sequences involved in nuclear trafﬁcking
Based on the fact that pp71 localizes predominantly to the nucleus
upon viral infection and in transfected cells (Hensel et al., 1996;Fig. 1. A and B. Subcellular localization of pp71 insertion mutants. HFF cells were co-transfec
processed for immunoﬂuorescence and confocal microscopy 48 h after transfection using p
Fluor® 488 and anti-rabbit Alexa Fluor® 546 as secondary antibodies. The pp71 proteins are
pp71in217 proteins are shown as representatives of the insertion mutant phenotypes as in
transfected with p760-CAT and pCMV71HAX or the indicated insertion mutants. Cells were
standard deviation of a minimum of three experiments, normalized to promoter activity in the
different from wild type, pb0.001. D. Western blot analysis of the pp71 insertion mutants. H
pSI71HAXin66 (lane 3), pSI71HAXin154 (lane 4), pSI71HAXin191 (lane 5), pSI71HAXin215 (l
post-transfection and the extracts subjected to western blot analysis using an antibody toHofmann et al., 2002; Marshall et al., 2002), we reasoned that pp71
contained an intrinsic nuclear localization signal, allowing it to be
actively imported into the nucleus. Initial sequence analysis of the
pp71559 amino acid open reading frame revealed a novel basic region
in the C-terminus from amino acids 362 to 383 that had some
similarity to nuclear localization signals (Christophe et al., 2000;
Dingwall and Laskey, 1991; Macara, 2001). However, preliminary
experiments showed that this region is not involved in nuclear
targeting (data not shown). Other than this basic region, pp71
contains no sequences with homology to known nuclear localization
signals. Thus, in order to map the protein domain(s) responsible for
nuclear localization of pp71, random insertion mutagenesis was
performed. This approach has been used successfully to map
functional domains within the major immediate early proteins
(Stenberg et al., 1990) and was selected to minimize the potential
impact of the mutations on protein conformation. The mutants were
generated by randomly inserting a 12 bp oligonucleotide linker into
the pp71 open reading frame, resulting in four amino acid insertions
within the amino-terminal region of pp71 at amino acids 66, 154, 191,
215, 217, and 284. The pp71 mutants were then transfected into HFF
cells along with a construct expressing the HCMV IE86 protein as a
marker for nuclear staining, and examined by immunoﬂuorescence
and confocal microscopy. The IE86 protein localizes exclusively to the
nucleus, co-localizing with the wild type pp71 protein which exhibits
predominantly nuclear staining (Figs. 1A and B). Proteins with
insertions at amino acids 66, 154, and 191 retained a predominantly
nuclear localization, similar to thewild type pp71 protein (Figs.1A and
B). However insertions at amino acids 215, 217, or 284 resulted in ated with constructs expressing the indicated pp71 insertion mutants and pMCRS86, and
rimary antibodies to the HA epitope tag of pp71 and IE86, with goat anti-mouse Alexa
shown as green ﬂuorescence, and IE86 shown as red ﬂuorescence. The pp71in154 and
dicated in B. C. Transcriptional activity of pp71 insertion mutants. HFF cells were co-
harvested 48 h post-transfection and assessed for CAT activity. Data is the average and
absence of pp71. Symbols: ⁎ signiﬁcantly different fromwild type, pb0.01; ⁎⁎ signiﬁcantly
eLa cells were transfected with the following plasmids: pSI (lane 1), pSI71HAX (lane 2),
ane 6), pSI71HAXin217 (lane 7) or pSI71HAXin284 (lane 8). Cellswere harvested at 48 h
the HA epitope tag. Symbol: ⁎ non-speciﬁc band used as a loading control.
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that sequences around amino acids 215–284, that we term the mid
region (MR), are important for the nuclear targeting of pp71.
As pp71 activates the major immediate early promoter (MIEP) and
initiates viral infection (Baldick et al., 1997; Liu and Stinski, 1992), we
investigated the transcriptional activity of these pp71 mutants using a
promoter–reporter assay. HFF cells were co-transfected with a CAT
reporter plasmid containing the immediately early promoter region
and expression plasmids containing either full-length pp71 or the
random insertion mutants. Cells were assessed for CAT activity 48 h
after transfection. This study showed that the insertion at aa 66 caused
an approximately 50% loss of pp71 activity (Fig. 1C). In contrast, the
insertions at aa 154 and 191 resulted in a slight but not signiﬁcant
(pN0.05) reduction in activity compared with the wild type protein.
However insertion at aa 215, 217, or 284 completely abrogated the
activity of pp71 (pb0.001). Similar results were obtained when pp71
enhancement of IE protein activation of the HCMV UL54 DNA
polymerase promoter was assessed (data not shown). These analyses
provide a functional assessment of pp71 nuclear targeting and
indicate that the insertions at aa 215, 217, and 284 disrupt nuclear
targeting to the extent that transactivation is abolished. One possible
explanation for the reduced activity of these pp71 mutants is that the
mutations affect protein stability. To assess this, we subcloned the
pp71 mutants into the pSI vector which expresses proteins under the
control of the SV40 promoter. This promoter is less responsive to auto-
activation by pp71 than the MIEP (data not shown) and therefore
provides a more accurate measure of steady-state pp71 protein levels.
Western blot analysis demonstrated that the pp71 mutants were
expressed at similar levels to the wild type protein (Fig. 1D). This
analysis conﬁrms that the decrease in activity that we observe is most
likely the result of the change in subcellular localization, and is not
related to major effects on the stability of the protein.Fig. 2. A. Subcellular localization of pp71 mutants generated by random mutagenesis. HF
processed for immunoﬂuorescence and confocal microscopy 48 h after transfection using ant
transfected with pMIEP-LUC and pSI71HAX or the indicatedmutants. Cells were harvested 48
deviation of a minimum of three experiments, normalized to promoter activity in the absenAnalysis of the random insertion mutants suggested that a
relatively large domain was involved in the nuclear targeting of
pp71. We therefore decided to utilize a random site-directed domain
mutagenesis approach in order to further map the sequences within
the MR responsible for nuclear targeting of pp71 as described in the
Materials and methods. This strategy was used to generate pp71
mutants between aa 200–300 in the pp71 open reading frame cloned
into the pSI vector. Using the random mutagenesis approach, we
identiﬁed ﬁve mutants that resulted in amino acid changes: three
single substitution mutants, M238I, H269Q, I287S, and two double
substitution mutants, P206T/T223M, T228M/L275Q. Localization of
these mutants was assessed by immunoﬂuorescence and confocal
microscopy (Fig. 2A). The three single substitution mutants did not
affect the nuclear targeting of pp71. In contrast, the two double
substitution mutants exhibited a reduction in the nuclear accumula-
tion of pp71, displaying a diffuse cytoplasmic ﬂuorescence with some
punctate staining, similar to that of the pp71 random insertion
mutants. We then investigated the transcriptional activity of these
pp71 mutants as a functional assessment of pp71 nuclear targeting
using a construct containing the MIEP upstream of the luciferase
reporter gene which provides for increased sensitivity over the CAT
reporter. As expected, the three single substitution mutants did not
signiﬁcantly affect pp71 transactivation, whereas the two double
substitution mutants signiﬁcantly reduced the activity of pp71
(pb0.05, Fig. 2B). Again, similar results were obtainedwhen activation
of the UL54 promoter by the pp71 mutants was assessed (data not
shown). These data demonstrate that nuclear localization is important
for the activity of pp71. In addition, these results clearly indicate that
the sequences required for nuclear localization of pp71 do not
correspond to a conventional nuclear localization signal. One
possibility is that interactions with a cellular protein via the mid
region of pp71 may be required for nuclear transport. PreliminaryF cells were transfected with constructs expressing the indicated pp71 mutants, and
ibodies to the HA epitope tag. B. Transcriptional activity of pp71 mutants. HFF cells were
h post-transfection and assessed for luciferase activity. Data is the average and standard
ce of pp71. Symbol: ⁎ signiﬁcantly different from wild type, pb0.05.
Fig. 3. Subcellular localization ofMR–eGFP fusion proteins. HFF cells were transfectedwith peGFP–N2 (A), p188MR–eGFP (B), p94MR–eGFP (C), or p62MR–eGFP (D) and processed for
confocal microscopy 48 h after transfection. HFF cells infected with HCMVwere processed for immunoﬂuoresence at 72 h post-infection and subjected to immunoﬂuorescence using
a monoclonal antibody to pp71 (E).
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by these mutations (data not shown), suggesting that this protein is
not involved in the nuclear transport of pp71.
To determine if the mid region (MR) is sufﬁcient for nuclear tar-
geting, a region containing aa 188–300 was cloned in frame with the
amino-terminus of eGFP (188MR–eGFP) and the localization of the
fusion protein examined (Fig. 3). As expected, eGFP alone can be de-
tected throughout the cell (Fig. 3A). Surprisingly, the 188MR–eGFP
fusion protein did not localize in the nucleus, but was distributed in a
distinct punctate perinuclear pattern (Fig. 3B) suggesting that while
sequences within the MR are important for nuclear localization, these
sequences are not sufﬁcient to independently direct nuclear targeting.Fig. 4. Characterization of pp71 cytoplasmic localization. HFF cells were transfected construct
48 h after transfection. Cells transfected with the construct expressing pp71T223D were stai
antibody to syntaxin 11 (red). Nuclei were stained with TOTO3 dye (blue).To assess if sequences adjacent to the MR domain participated in the
nuclear localization of pp71, we generated additional eGFP fusion
protein constructs containing sequences from aa 94–300 (94MR–eGFP)
and 62–300 (62MR–eGFP). Confocal microscopy analysis revealed that
amino acids 94 to 300 of pp71 were sufﬁcient to mediate nuclear tar-
geting (Fig. 3C), suggesting that sequences adjacent to theMR inﬂuence
recognition of the pp71 nuclear localization signal. To identify the
locationof theperinuclearﬂuorescence observedwith the188MR–eGFP
fusion protein, HFF cells were transfected with this construct and co-
stained with a series of subcellular markers including a panel of Golgi-
related antibodies. These studies showed that the perinuclear ﬂuores-
cence associatedwith 188MR–GFP colocalizedwith syntaxin 6 (data nots expressing p188MR–eGFP (A) or pp71T223D (B) and processed for confocal microscopy
ned using and antibody to the HA epitope tag (green) and both were co-stained with an
46 W. Shen et al. / Virology 376 (2008) 42–52shown) and syntaxin 11 (Fig. 4A), SNAREs that are localized to the TGN-
late endosomal compartment (Teng et al., 2001). We also observed
partial co-localizationwith other late TGNmarkers, including GS27 and
Vti1a (data not shown). This staining pattern is reminiscent of that
observed for pp71 at the late times of viral infection (Figs. 3E and 7A
(Hensel et al., 1996)) and may correspond to the site of cytoplasmic
tegumentation (Mettenleiter, 2004).Fig. 5. A. Phosphopeptidemap of pp71. A compilation of the results obtainedwith MS/MS ana
is underlined, and the phosphorylated residues are indicated in red. The region correspon
phosphorylation site mutants. HFF cells were transfected with pMIEP-LUC and pSI71HAX o
luciferase activity. Data is the average and standard deviation of a minimum of three experim
⁎ signiﬁcantly different fromwild type, pb0.05. C. Subcellular localization of pp71 phosphory
pp71 mutants, and processed for immunoﬂuorescence and confocal microscopy 48 h after tr
proteins are shown as red ﬂuorescence, and ND10 domains shown as green ﬂuorescence. D. W
with constructs expressing eGFP (lane 1), pp71 (lane 2), pp71T223A (lane 3), or pp71T223D
western blot analysis using an antibody to the HA epitope tag. Symbol: ⁎ non-speciﬁc bandPhosphorylation regulates pp71 trafﬁcking
Using the random mutagenesis strategy, we identiﬁed two
threonine residues that play a role in the subcellular trafﬁcking of
pp71 (Fig. 2). Based on these ﬁndings, we speculated that phosphor-
ylation events may be involved in regulating the subcellular localiza-
tion of pp71. To address this hypothesis, we puriﬁed pp71 protein fromlysis of phosphorylation sites of the pp71 tegument protein. The total analyzed sequence
ding to the Mid-Region (MR, aa 200–300) is boxed. B. Transcriptional activity of pp71
r the indicated mutants. Cells were harvested 48 h post-transfection and assessed for
ents and is expressed relative to the activity of the wild type (WT) pp71 protein. Symbol:
lation site mutants. HFF cells were transfected with constructs expressing the indicated
ansfection using antibodies to the HA epitope tag and nuclear ND10 domains. The pp71
estern Blot analysis of pp71 phosphorylation site mutants. HeLa cells were transfected
(lane 4). Cells were harvested at 48 h post-transfection and the extracts subjected to
used as a loading control.
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resultant protein was subjected to phosphopeptide mapping using
LC-MS/MS (Durkin et al., 2006). Using this approach, we detected
phosphorylation of nine residues within the pp71 open reading frame
(Fig. 5A). Within the MR, a single residue, the threonine residue at
amino acid position 223 (T223) was found to be phosphorylated. A
rapid semi-quantitative assessment of the total tryptic peptides
derived from the wild type pp71 protein analyzed by mass spectro-
metry revealed that 25% of the peptides were phosphorylated at
position T223, indicating that the majority of pp71 in transfected cells
was not phosphorylated at this site. To assess the effect of T223
phosphorylation on pp71 trafﬁcking, wemutated this residue to either
alanine in order to block phosphorylation, or an aspartic acid to mimic
phosphorylation within the context of the full-length pp71 protein.
Assessment of the T223 mutants in transfection assays showed that
mutation of amino acid 223 to an alanine (T223A) resulted in a
reduction of the activity of pp71 (Fig. 5B). However, mutation of this
residue to aspartic acid (T223D) reduced transcriptional enhancement
to a level not signiﬁcantly different to the promoter activity observed
in the absence of pp71 (p=0.67). We next assessed the effect of the
T223 mutations on the localization of pp71 (Fig. 5C). The T223A
mutant displayed an identical localization to the wild type pp71
protein, co-localizing with ND10 domains within the nucleus. In
contrast, substitution of T223 with the phosphomimetic amino acid
abrogated nuclear import of pp71, resulting in a punctate cytoplasmic
localization. Analysis of the cytoplasmic localization of the pp71T223D
protein revealed co-localization with syntaxin 11 (Fig. 4B), consistent
with the results obtainedwith the 188MR–GFP fusion protein (Fig. 4A).
Analysis of the transfected cells by western blot using an antibody to
theHA-tag showed lower levels of protein in cells transfectedwith pp71
containing either mutation of threonine 223 (Fig. 5D). The decrease in
protein levels could arise from the reduction in activity of the mutants,
resulting in diminished auto-regulation of the SV40 promoter construct
used to express pp71. However, the SV40 promoter displays minimal
(approximately than 2-fold) activation by pp71 which would not
account for the marked decrease in protein levels observed. Alterna-
tively, this could indicate adecrease in the stabilityof theproteindue to a
conformational change resulting from the mutation of this residue. To
assess this, we inserted the SV40 nuclear localization signal (NLS) into
the amino-terminus of both thewild type and pp71T223Dopen reading
frames in order to independently target the protein to the nucleus. This
analysis showed that localization of the pp71T223D mutant to theFig. 6. A. Transcriptional activity of pp71 mutants containing the SV40 NLS. HFF cells were tra
48 h post-transfection and assessed for luciferase activity. Data is the average and standard d
the wild type (WT) pp71 protein. Symbol: ⁎ signiﬁcantly different from wild type, pb0.01
transfected with constructs expressing the indicated pp71 mutants, and processed for immu
HA epitope tag and nuclear ND10 domains. The pp71 proteins are shown as green ﬂuorescenucleus via the SV40 NLS did not result in restoration of pp71 activity
(Fig. 6A). This ﬁnding is consistent with the phosphomimetic mutation
causing a conformational change in pp71. Surprisingly, insertion of the
SV40 NLS into the wild type protein signiﬁcantly enhanced the activity
of pp71 (Fig. 6A). Thus, it is possible that the addition of the SV40 NLS
enhances nuclear import of pp71, or blocks nuclear export of this
protein. To conﬁrm the nuclear localization of the pp71 proteins
containing the SV40 NLS, we performed immunoﬂuorescence studies
(Fig. 6B). This analysis showed thatboth thewild typepp71and thepp71
T223Dmutant proteins containing the SV40NLS localized to thenucleus
of transfected cells. However, both proteins displayed only partial co-
localization with ND10 domains, suggesting that the SV40 NLS
inﬂuences the subnuclear localization of pp71.
The trafﬁcking of the pp71 tegument protein to the TGN-endosomal
compartment when nuclear import is inhibited may be related to the
ﬁnding that pp71 localizes to a punctate perinuclear region at the late
stages of virus infection (Hensel et al., 1996), thought to be sites of
tegumentation. To investigate this further we performed transfection/
superinfection experiments to assess the localization of these pp71
mutants at the late stagesof virus infectionwhenvirionmorphogenesis is
occurring. In our initial experiments, we conﬁrmed that during infection,
the transfectedpp71protein colocalizedwith endogenouspp71 (datanot
shown), and that endogenous pp71 localizes adjacent to gB (Fig. 7A), a
marker for virus assembly compartments (Homman-Loudiyi et al., 2003;
Jarvis et al., 2004; Sanchez et al., 2000). Analysis of the co-transfected
cells showed that both the wild type pp71 and the pp71T223D protein
localized to the cytoplasmwith some evidence of co-localizationwith gB
(Figs. 7B and D), suggesting that cytoplasmic pp71 localization partially
overlaps the virus assembly compartments (Homman-Loudiyi et al.,
2003;Krzyzaniaket al., 2007; Sanchezet al., 2000). Surprisingly, thepp71
protein containing the T223A substitution that is unable to be
phosphorylated displayed a similar pattern of localization (Fig. 7C),
indicating that thismutant protein is capable of cytoplasmic trafﬁcking at
the late stages of virus infection. These studies indicate that viral and/or
cellular proteins that may be modiﬁed by infection are important for
pp71 nuclear export at the late stages of infection and suggest that
nuclear import and export are controlled via different mechanisms.
Discussion
Transport of proteins into the nucleus occurs via two primary
mechanisms, either via passive diffusion or byactive transport throughnsfected with pMIEP-LUC and pSI71HAX or the indicated mutants. Cells were harvested
eviation of a minimum of three experiments and is expressed relative to the activity of
. B. Subcellular localization of pp71 mutants containing the SV40 NLS. HFF cells were
noﬂuorescence and confocal microscopy 48 h after transfection using antibodies to the
nce, and ND10 domains shown as red ﬂuorescence.
Fig. 7. Subcellular localization of pp71 at the late stages of virus infection. HFF cells were infected with HCMV strain AD169 (A) and ﬁxed at 96 h post-infection. The cells were then
subjected to immunoﬂuorescence using a monoclonal antibody to pp71 to or a polyclonal antibody to gB. Alternatively, HFF cells were transfected with constructs expressing pp71
(B), pp71T223A (C), or pp71T223D (D) and subsequently infected with HCMV strain AD169. Cells were ﬁxed at 96 h post-infection and subjected to immunoﬂuorescence using an
antibody to the HA epitope tag of pp71 (green) and the gB protein (red). Nuclei were stained with TOTO3 dye (blue).
48 W. Shen et al. / Virology 376 (2008) 42–52nuclear pore complexes (Macara, 2001). Based on itsmolecularweight,
pp71 most likely contains a nuclear targeting signal allowing it to be
actively transported into nucleus. In the current study, we determined
that mutations within the mid region (MR) of pp71, consisting of
sequences from aa 200–300 disrupted nuclear accumulation of pp71,
suggesting that the MR domain is important for the nuclear import of
this protein. This ﬁnding is consistent with studies using a transposon
mutagenesis approach demonstrating that insertions within the
central domain of pp71 disrupted nuclear trafﬁcking (Willey, S. J. and
Preston, C.M., personal communication).We further show that nuclear
localization of pp71 is necessary, although not sufﬁcient, for its
transcriptional activities, consistent with the mechanism of pp71
transactivation via Daxx degradation (Cantrell and Bresnahan, 2005,
2006; Hwang and Kalejta, 2007; Saffert and Kalejta, 2006, 2007). It
should be noted thatwe observed somevariability in the assessment of
pp71 activity that reﬂects the nature of these transient transfection
studies, although the mutants that displayed disruption of pp71
nuclear trafﬁcking all exhibited signiﬁcantly lower activity than the
wild type protein. In addition, our studies show that the threonine
residue at position 223 within theMR plays a critical role in regulating
the subcellular trafﬁcking of pp71. Mass spectrometric analysis
demonstrated that T223 can be phosphorylated, and our data strongly
suggests that phosphorylation at this site inﬂuences nuclear import.
Other studies have reported the effects of mutations within the MRdomain of pp71, as this region contains one of two Daxx interaction
domains, as well as the Rb-interaction motif (Cantrell and Bresnahan,
2005; Hofmann et al., 2002; Kalejta et al., 2003). These analyses
demonstrated that mutation of aa 219 from cysteine to glycine that
disrupts the Rb-interaction motif (Kalejta et al., 2003) had no affect on
virus replication, suggesting that nuclear importwas unaffected by this
mutation (Cantrell and Bresnahan, 2005). Likewise, deletion of the
Daxx interaction domain from aa 206–213, while disrupting pp71
transcriptional activation, had no affect on nuclear import (Cantrell
and Bresnahan, 2005; Hofmann et al., 2002). Taken together, these
studies support the notion that the effect of the pp71T223D mutation
on nuclear import is speciﬁc to this residue and not a generic effect of
mutations within the MR domain.
Analysis of the mid region fusion proteins demonstrated that
sequences from aa 188–300 were unable to independently target
proteins to the nucleus. These ﬁndings suggest that while the mid
region of pp71 is necessary for the nuclear trafﬁcking of pp71, it is not
sufﬁcient to target proteins to the nucleus. Further, these ﬁndings
suggest that the higher-ordered structure of the pp71 protein or
amino acids outside this essential region also play a role in subcellular
targeting. Together, our data suggest that the pp71 mid region
contains an unconventional, non-sequential, long nuclear targeting
sequence that may be conformation sensitive. However, the mechan-
ism by which the T223 phosphomimetic mutation affects nuclear
49W. Shen et al. / Virology 376 (2008) 42–52import is currently unclear. Our currentmodel is that phosphorylation
of T223 alters the conformation of pp71, such that recognition of the
nuclear import sequence is blocked. This effect is likely to be speciﬁc
as other mutations and deletions within this region had no effect on
pp71 nuclear import (Cantrell and Bresnahan, 2005; Hofmann et al.,
2002). An alternative possibility is that phosphorylation of this
residue affects the interaction with a cellular protein required for
nuclear transport. Our preliminary experiments suggest that Daxx-
interaction is not sufﬁcient for nuclear import (data not shown). The
identiﬁcation of additional cellular pp71-interacting proteins would
help to address this question.
A recent study has shown that nuclear import of pp71 can be
inhibited upon infection of in vitromodels of quiescent or “latent-like”
infections (Saffert and Kalejta, 2007). Speciﬁcally, this study showed
that nuclear import of pp71 was blocked in non-permissive THP-1
cells, and that this block contributes, at least in part, to the defect in
virus replication. In contrast, pp71 nuclear import was unaffected
when these cells are induced to their permissive states, suggesting
that the block in pp71 nuclear import is a cell speciﬁc effect (Saffert
and Kalejta, 2007). However, the precise mechanism by which pp71
nuclear import is regulated in these cell types is currently unclear. Our
ﬁndings suggest that the phosphorylation of the threonine residue at
position 223 may be important in this phenomenon. Speciﬁcally, our
studies revealed that T223 can be phosphorylated by a cellular kinase,
consistent with a cell speciﬁc effect. Analysis of the sequence
surrounding T223 using Scansite software did not result in any
matches to known cellular kinase recognition motifs, even when the
search was conducted at a low stringency (Obenauer et al., 2003).
Thus, it is unclear at this point which cellular kinase is involved in
phosphorylating pp71 at this site. However, our ﬁndings are
consistent with other studies that show both cellular and viral kinases
associate with HCMV tegument proteins, and phosphorylation events
modulate their function and/or localization. For example, the HCMV
pp65 protein interacts with a cellular polo-like kinase, although the
phosphorylation targets of this complex have yet to be deﬁned
(Gallina et al., 1999). The HCMV UL97 kinase may also be a component
of the virion tegument (van Zeijl et al., 1997) and UL97 kinase activity
is important for pp65 subcellular localization and virion morphogen-
esis (Prichard et al., 2005). Interestingly, the cellular phosphatase
PP2A is also a component of HCMV particles (Michelson et al., 1996),
suggesting the possibility of ﬁnely-tuned regulation of virion protein
phosphorylation. Other studies demonstrated that of three differen-
tially phosphorylated forms of the HCMVUL69 tegument protein, only
one form is actually incorporated into the tegument of virion particles
(Winkler and Stamminger, 1996). In addition, cyclin-dependent
kinases can modulate the phosphorylation state and localization of
UL69 and pp65 (Sanchez et al., 2007; Sanchez and Spector, 2006).
Together, these studies demonstrate that differential phosphorylation
can inﬂuence both subcellular localization and virion incorporation of
the HCMV tegument proteins. In addition, HCMV infection can
inﬂuence both the localization and activity of a number of cellular
kinases (Hakki et al., 2006; Kudchodkar et al., 2004; Sanchez et al.,
2004; Tamrakar et al., 2005), suggesting the possibility of differential
regulation of virion protein phosphorylation during the course of
infection. Our ﬁndings are therefore consistent with a model whereby
phosphorylation of pp71 modulates the subcellular localization of this
tegument protein to enable efﬁcient virus replication.
While our studies suggest that phosphorylation of T223 regulates
the nuclear import of pp71, the mechanism that controls nuclear
export at the late stages of infection is less clear. Recent studies
suggest that cyclin-dependent kinases play a role in pp65 nuclear
egress at the late stages of infection (Sanchez et al., 2007), and a
similar mechanism may be involved in regulating pp71 cytoplasmic
localization. Analysis of the 188MR–eGFP protein and the pp71T223D
mutant revealed that pp71 also contains a sequence that targets
proteins to a distinct perinuclear region that colocalizes with syntaxin6 and syntaxin 11, markers of the TGN-late endosomal compartment
(Teng et al., 2001). Trafﬁcking to this region is consistent with ﬁndings
that pp71 is localized to a punctate perinuclear region at late times of
infection (Hensel et al., 1996), that may corresponds to sites of viral
tegumentation (Mettenleiter, 2004). Also of note are ﬁndings that in
non-permissive cell lines where nuclear import of pp71 is blocked, the
protein localizes to punctate perinuclear region (Saffert and Kalejta,
2007). The presence of a domain that enables perinuclear targeting
within pp71 suggests that relocalization at the late stages of infection
is an inherent property of this protein to allow for complete
tegumentation during virion morphogenesis. Two models have been
proposed by which nuclear tegument proteins become incorporated
into the virion (Mettenleiter, 2004). Firstly, nuclear tegument proteins
may associate with nascent nucleocapsids and trafﬁc to the cytoplasm
together with the nucleocapsids. Second, the viral tegument proteins
may independently trafﬁc to the cytoplasm to speciﬁc tegumentation
sites where they then associate with the newly formed capsids. Our
studies showing that the pp71T223D mutant protein can indepen-
dently trafﬁc to a speciﬁc cytoplasmic site that partially overlaps
previously characterized virus assembly compartments would be
consistent with this latter model. However, analysis of the location of
the pp71T223A mutant at the late stages of infection demonstrating
that viral and/or cellular proteins modiﬁed by virus infection can
regulate the nuclear export of pp71 could be consistent with either
model. Further analysis of these mutant proteins in the context of
virus infection will be necessary to distinguish between these two
models.
In summary, we have identiﬁed an unconventional non-sequential
NLS sequence in themid region of pp71which is sufﬁcient for targeting
pp71 to the nucleus. This NLS appears to be conformational sensitive,
and does not ﬁt any known consensus motifs. In addition, sequences
targeting pp71 to a distinct perinuclear regionwere identiﬁed. Further,
our studies strongly suggest that differential phosphorylation events
modulate the subcellular localization of pp71. Our observations
provide novel insight into themechanisms that regulate the trafﬁcking
of this key viral protein, and offer useful tools for a full understanding
of the functions of pp71 in HCMV infection, assembly and egress.
Materials and methods
Plasmids
The plasmids pSVH and pSV0d have been previously described
(Stenberg et al., 1990). The plasmids pCMV71 and p760CAT were
obtained from Dr. Mark Stinski. The pMIEPLuc plasmid was con-
structed by inserting themajor immediate early promoter region from
p760CAT into pGL2Basic (Promega). The plasmid pCMV71 was
modiﬁed by the insertion of the inﬂuenza hemagglutinin (HA) epitope
tag immediately downstream of the initiating AUG codon by over-
lapping PCR mutagenesis using primer HA-1 (Table 1) to generate
plasmid pCMV71HA. An additional Xba I site was also introduced
immediately upstream of the pp71 ORF by PCR using primer 71X-1 to
generate pCMV71HAX. The resultant Xba I fragment was then cloned
into pBSKS(+) (Stratagene) modiﬁed by the deletion of the Kpn I site
(pBSKN71HAX). Random insertion mutants within the pp71 open
reading framewere generated as previously described (Stenberg et al.,
1990). Brieﬂy, the pCMV71 plasmid was partially digested with either
Hae III or Pvu II and the linear DNA isolated. A 12 nt linker containing a
unique Bst BI site (5′ CGCTTCGAAGCG) was ligated to the linear DNA
and the plasmid recircularized. Clones that contained Bst BI sites were
identiﬁed by restriction enzyme digestion and the site of insertion
conﬁrmed by complete sequencing of the pp71 open reading frame.
Some insertion mutants that contained multiple copies of the linker
were further digested with Bst BI, and recircularized, resulting in a
single copy of the linker. Mutants were subcloned by inserting the Not
I and Bsm I fragments from pCMV71 into pBSKN71HAX. The resultant
Table 1
Primers used for mutagenesis
Primer name Primer sequence Purpose
HA-1 5′-CCGCCTTCGCAATGTACCCATACGATGTTCCAGATTACGCTTCTCAGGCATCGTCC Introduce HA-Tag sequence
71X-1 5′-TTGCCGGAACCCTTCTAGACCTCCCACGAAGAC Introduce Xba I site 5′ of pp71 ORF
MRS 5′-GCAGATCTTTGTCAGCCAGT Amplify MR for random mutagenesis
MRAS 5′-TGACTCGGGATGTATGCGC Amplify MR for random mutagenesis
pp7162MR-For 5′-CTCGAGTCTCTGCTGTTTTC Introduce Xho I site for eGFP–62MR cloning
pp7162MR-N 5′-CTCGAGGAACTTCGTGCCACCATGGAGGTG N-terminal primer for 62MR–eGFP cloning
pp7194MR-N 5′-CTAAACATCAAGGAGCTCACCATGGTGGGCG N-terminal primer for 94MR–eGFP cloning
pp71188MR-N 5′-GCAGAACCGAGCTCACCATGGAGG N-terminal primer for 188MR–eGFP cloning
pp71MR-Rev 5′-GTACCCGGGATGTATGCG Introduce Xma I site for MR–eGFP cloning
S-tag1 5′-CGCCTTCGCAATGAAAGAAACCGCTGCTGCGAAATTTTCTCAGGCATCGTCC Introduce 8 aa of the S-tag sequence
S-tag2 5′-GCTGCTAAATTTGAACGCCAGCACATGGACTCGTCTCAGGCATCGTCC Introduce 7 aa of the S-tag sequence
SV40 5′-GATGTTCCAGATTACGCTCCAAAGAAGAAGAGAAAGGTGTCTCAGGCATCGTCCTCG Introduce the SV40 NLS
Mutated sequences are underlined. For primers used in PCR mutagenesis procedures, only the forward primer sequence is shown.
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then subcloned into the ﬁnal expression vectors pSI (Promega) and
pRc/RSV (Invitrogen).
Random mutagenesis of the MR domain (amino acids 198–294)
was performed using the GeneMorph® II EZClone Domain Mutagen-
esis kit (Stratagene) using the MRS and MRAS primers (Table 1). Mid
region (MR)–eGFP fusion protein constructs were generated using
PCR-based mutagenesis and standard cloning. Brieﬂy, the pp71 mid
region sequences from amino acids 62, 94, and 188 to 300 were
ampliﬁed using the appropriate forward primers with a common
reverse primer (Table 1). The PCR products were cloned into pCR4-
TOPO, sequenced and then subcloned into peGFP-N2 to generate
p62MR–eGFP, p94MR–eGFP and p188MR–eGFP. Insertion of the
SV40NLS into the pp71 open reading frame immediately downstream
of the HA epitope tag was performed using the Quikchange mutagen-
esis procedure (Stratagene) with the appropriate primers (Table 1).
Cells and transient transfection
Human foreskin ﬁbroblasts (HFF) were grown in minimal essential
medium supplementedwith 10% newborn calf serum and 1% penicillin,
streptomycin and glutamine. HFFs were transfected using the DEAE-
dextran method as previously described (Stenberg et al., 1989) or using
Lipofectamine 2000 according to themanufacturer's directions (Invitro-
gen Corporation). HeLa cells (ATCC) were maintained in Iscove's me-
dia supplemented with 10% fetal calf serum and 1% penicillin and
streptomycin and transfected using standard calcium-phosphate
procedures.
Reporter assays and Western blot analysis
HFF cells were co-transfected with either p760CAT or pMIEPLuc
and the corresponding expression vectors containing either wild type
or mutant pp71. Cells were harvested 48 h post-transfection and
assessed for either CAT activity or luciferase activity using the lucif-
erase assay kit (Promega) and a TD-20/20 luminometer (Turner
designs).Western Blot analysiswas performed as previously described
(Ciocco-Schmitt et al., 2002) using a monoclonal antibody to the HA-
tag (12CA5, Roche Applied Science).
Immunoﬂuorescence
HFF cells were transfected and seeded onto 2-well permanox™
chamber slides or 8-chamber cover glasses pretreated with 2% gelatin
(Nalge Nunc International) 24 h post-transfection. After an additional
24 h, HFF cells were ﬁrst ﬁxedwith 4% paraformaldehyde for 10min at
room temperature, washed twice with PBS, and then ﬁxed with 100%
methanol for 2 min and washed four times with PBS. HFF cells were
permeabilized with 0.1% Triton X-100 in PBS for 10 min at roomtemperature and blocked with 5% normal goat serum (NGS) in PBS for
45 min at 37 °C. Primary antibodies were diluted in PBS containing 5%
NGS, and added to HFF cells for 45 min including 1218 peptide
antibody to IE86 (Stenberg et al., 1989), anti-HA (12CA5, Roche
Applied Science) or HA-probe (Y-11, Santa Cruz Biotechnology, Inc.) to
pp71 and anti-PML (PG-M3, Santa Cruz Biotechnology, Inc.). Cellswere
washed 3 times with PBS containing 0.1% BSA and incubated with
ﬂuorochrome-conjugated secondary antibodies (goat anti-rabbit Alexa
Fluor® 546, anti-mouse Alexa Fluor® 488, Molecular Probes) diluted in
5% NGS in PBS as indicated by the manufacturers for 45 min at 37 °C.
Following three washes with 0.1% BSA in PBS, the cells were washed 2
timeswith sterilewater, dried in a fume hood, and ﬁnallymountedwith
cover glass using vecta-shield mounting medium (Vector Laboratories,
Inc.) and assessed byconfocalmicroscopyusing a Zeiss LSM510 confocal
microscope and the images analyzed usingMetamorph. Identiﬁcation of
the cytoplasmic localization of pp71was performed by co-stainingwith
a panel of antibodies to Golgi-related markers (BD Biosciences). Nuclei
were stained using the TOTO3 dye (Invitrogen Corporation) according to
themanufacturer's directions. Immunoﬂuorescenceof infectedcellswas
performed at 72 or 96 h post-infection by the AD169 strain using a
monoclonal antibody to gB kindly provided by Dr. W. J. Britt (University
of Alabama School of Medicine, Birmingham), a polyclonal antibody to
the gB protein provided by Dr. T. Compton (Novartis Institutes for
BioMedical Research) or an antibody to pp71 providedbyDr. R. F. Kalejta
(University of Madison-Wisconsin).
S-tag protein puriﬁcation and mass spectrometry
The pBSKN71HAX plasmid was subjected to a two-step mutagen-
esis procedure (Quikchange, Stratagene) using the S-tag1 and S-tag2
primers (Table 1) to introduce the 15 amino acid sequence correspond-
ing to the S-tag (Hackbarth et al., 2004). The resultant Xba I fragment
was then subcloned into pSI to generate pSI71S. This plasmidwas then
transfected into HeLa cells using a standard calcium-phosphate
procedure. Approximately 1.5×107 transfected cells were harvested
and the cell nuclei isolated as previously described (Kerry et al., 1994),
except for the addition of 1 mM sodium vanadate in the buffers. The
resultant nuclear extracts were then subjected to S-tag afﬁnity
chromatography essentially as described by the manufacturer (Nova-
gen). Bound proteinswere elutedwith 1× SDS-PAGEGel Loading Buffer
and treated for 20min at 95 °C to reverse the formaldehyde cross-links.
Proteins were then separated on a 4–20% SDS-PAGE gel and visualized
with a Bio-Safe Coomassie staining kit (Bio-Rad).
Protein bands were excised from 1-D polyacrylamide gels. Gel
slices were cut into 1–2 mm cubes; washed 3× with 500 µl Ultra-pure
water and incubated in 100% acetonitrile for 45 min. Samples were
reduced with 50 mM DTT at 56 °C for 45 min then alkylated with
55 mM iodoacetamide for 1 h at room temperature. The material was
dried in a speed-vac, rehydrated in a 12.5 ng/µl modiﬁed sequencing
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bath for 40–45min. The excess trypsin solutionwas then removed and
replaced with 40–50 µl of 50 mM ammonium bicarbonate, 10%
acetonitrile, pH 8.0 and the mixture was incubated overnight at 37 °C.
Peptides were extracted 2× with 25 µl 50% acetonitrile, 5% formic acid
and dried in a speed-vac. Digests were resuspended in 20 µl Buffer A
(5% Acetonitrile, 0.1% Formic Acid, 0.005% heptaﬂuorobutyric acid)
and 3–6 µl were loaded onto a 12-cm×0.075 mm fused silica capillary
column packed with 5 µM diameter C-18 beads (The Nest Group,
Southboro, MA) using a N2 pressure vessel at 1100 psi. Peptides were
eluted over 55 min, by applying a 0–80% linear gradient of Buffer B
(95% Acetonitrile, 0.1% Formic Acid, 0.005% HFBA) at a ﬂow rate of
150 µl/minwith a pre-column ﬂow splitter resulting in a ﬁnal ﬂow rate
of ~200 nl/min directly into the source. In some cases, the gradientwas
extended to 150min to acquiremoreMS/MS spectra. A LTQ™ Linear Ion
Trap (ThermoFinnigan, San Jose, CA) was run in an automated collection
mode with an instrument method composed of a single segment and 5
data-dependent scan events with a full MS scan followed by 4 MS/MS
scans of the highest intensity ions. Normalized collision energy was set
at 35, activation Qwas 0.250 withminimum full scan signal intensity at
1×105 with no minimum MS2 intensity speciﬁed. Dynamic exclusion
was turned on utilizing a three minute repeat count of 2 with the mass
width set at 1.0 m/z. Sequence analysis was performed with TurboSE-
QUEST™ (ThermoFinnigan, San Jose, CA) or MASCOT (Matrix Sciences,
London GB) using an indexed viral subset database of the non-
redundant protein database from National Center for Biotechnology
Information (NCBI) web site (http://www.ncbi.nlm.nih.gov/).
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